
BioStrand
BioStrand, a subsidiary of ImmunoPrecise Antibodies (IPA), offers advanced data management and analytics for life sciences, focusing on in silico drug discovery and development.
Their patented LENSai™ Integrated Intelligence Technology, powered by HYFTs®, excels in integrating diverse data sources. This integration not only enhances drug development efficiency but also provides a comprehensive view of biological systems, enabling a deeper understanding of the relationships between genes, proteins, and other molecular components.
They are committed to transforming biomedicine with cutting-edge data integration, driving forward the development of next-generation therapies by facilitating faster and more informed decisions.